These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2353080)

  • 1. Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086.
    Abdel-Nabi HH; Levine G; Lamki LM; Murray JL; Tauxe WN; Shah AN; Patt YZ; Doerr RJ; Klein HA; Gona J
    Radiology; 1990 Jul; 176(1):117-22. PubMed ID: 2353080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.
    Abdel-Nabi HH; Schwartz AN; Higano CS; Wechter DG; Unger MW
    Radiology; 1987 Sep; 164(3):617-21. PubMed ID: 3303117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
    Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
    J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
    Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
    J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results.
    Abdel-Nabi H; Doerr RJ; Chan HW; Balu D; Schmelter RF; Maguire RT
    Radiology; 1990 Apr; 175(1):163-71. PubMed ID: 2315476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3.
    Doerr RJ; Abdel-Nabi H; Baker JM; Steinberg S
    Arch Surg; 1990 Dec; 125(12):1601-5. PubMed ID: 2244814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
    Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
    Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
    Halpern SE; Dillman RO; Witztum KF; Shega JF; Hagan PL; Burrows WM; Dillman JB; Clutter ML; Sobol RE; Frincke JM
    Radiology; 1985 May; 155(2):493-9. PubMed ID: 3983401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.
    Chaudhry A; Carrasquillo JA; Avis IL; Shuke N; Reynolds JC; Bartholomew R; Larson SM; Cuttitta F; Johnson BE; Mulshine JL
    Clin Cancer Res; 1999 Nov; 5(11):3385-93. PubMed ID: 10589749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary lung cancer: biodistribution and dosimetry of two In-111-labeled monoclonal antibodies.
    Brown PH; Krishnamurthy GT; Turner FE; Denney RK; Gilbert SA; Slauson ME
    Radiology; 1989 Dec; 173(3):701-5. PubMed ID: 2510212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
    Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
    Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
    J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
    Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
    Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments.
    Moldofsky PJ; Powe J; Mulhern CB; Hammond N; Sears HF; Gatenby RA; Steplewski Z; Koprowski H
    Radiology; 1983 Nov; 149(2):549-55. PubMed ID: 6622704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast.
    Williams MR; Perkins AC; Campbell FC; Pimm MV; Hardy JG; Wastie ML; Blamey RW; Baldwin RW
    Clin Oncol; 1984 Dec; 10(4):375-81. PubMed ID: 6391773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
    Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA
    Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of radionuclide diagnostic methods in the detection of distant metastases of lung cancer].
    Zubov GS; Fadeev NP; Mitreĭkin VF; Keller IuM
    Med Radiol (Mosk); 1984 Jan; 29(1):18-21. PubMed ID: 6694539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.